| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 4 | |
| #2 | Colombia | 3 | |
| #3 | South Africa | 3 | |
| #4 | Canada | 2 | |
| #5 | China | 2 | |
| #6 | EPO (European Patent Office) | 2 | |
| #7 | Cuba | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Medical preparations | |
| #4 | Acyclic or carbocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Stonans Ilmars | 10 |
| #2 | Kalvins Ivars | 9 |
| #3 | Dambrova Maija | 4 |
| #4 | Armands Zandersons | 4 |
| #5 | Jonane-Osa Indra | 4 |
| #6 | Inese Reine | 4 |
| #7 | Vilskersts Reinis | 3 |
| #8 | Uldrikis Janis | 3 |
| #9 | Vigante Brigita | 3 |
| #10 | Zuka Liga | 3 |
| Publication | Filing date | Title |
|---|---|---|
| WO2014032735A1 | Use of 3-(2,2,2-trimethylhydrazinium)-ethylpropionate or a pharmaceutically acceptable salt for treating high tension glaucoma | |
| EP2694474A1 | 4r,5r-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity | |
| CN103189354A | Derivatives of 1,4-dihydropyridine possessing antiviral efficacy | |
| WO2009095445A1 | New second medical use of 3-(2,2,2-trimethylhydrazine)propionate dihydrate |